title: Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas.
abstract: BACKGROUND
  Glucose tolerance (GT) has not been taken into consideration in investigations concerning relationships between coagulopathy and multiple organ dysfunction syndrome (MODS), and endothelial cell activation/endothelial cell injury (ECA/ECI) in septic patients, although coagulopathy is known to be influenced by blood glucose level. We investigated those relationships under strict blood glucose control and evaluation of GT with the glucose clamp method by means of the artificial pancreas in nine septic patients with glucose intolerance. The relationships between GT and blood stress related hormone levels (SRH) were also investigated.
  
  
  METHODS
  The amount of metabolized glucose (M value), as the parameter of GT, was measured by the euglycemic hyperinsulinemic glucose clamp method, in which the blood glucose level was clamped at 80 mg/dl under a continuous insulin infusion rate of 1.12 mU/kg per min, using the artificial pancreas, STG-22. Multiple organ failure (MOF) score was calculated using the MOF criteria of Japanese Association for Critical Care Medicine. Regarding coagulopathy, the following parameters were used: disseminated intravascular coagulation (DIC) score (calculated from the DIC criteria of the Ministry of Health and Welfare of Japan) and the parameters used for calculating DIC score, protein-C, protein-S, plasminogen, antithrombin III (AT-III), plasminogen activator inhibitor-1 (PAI-1), and tissue plasminogen activator-PAI-1 (tPA-PAI-1) complex. Thrombomodulin (TM) was measured as the indicator of ECI.
  
  
  RESULTS
  There were no significant correlations between M value and SRH, parameters indicating coagulopathy and the MOF score. The MOF score and blood TM levels were positively correlated with DIC score, thrombin-AT-III complex and tPA-PAI-1 complex, and negatively correlated with blood platelet count.
  
  
  CONCLUSIONS
  GT was not significantly related to SRH, coagulopathy and MODS under strict blood glucose control. Hypercoagulability was closely related to MODS and ECI. Among the parameters indicating coagulopathy, tPA-PAI-1 complex, which is considered to originate from ECA, seemed to be a sensitive parameter of MODS and ECI, and might be a predictive marker of MODS. The treatment for reducing hypercoagulability and ECA/ECI were thought to be justified as one of the therapies for acutely ill septic patients.
authors: Department of Intensive and Critical Care Medicine, Tokyo Police Hospital, Chiyoda-ku, Tokyo, Japan. noel2000@aioros.ocn.ne.jp
authors: M
authors: M
authors: Hoshino
authors: Y
authors: Y
authors: Haraguchi
authors: H
authors: H
authors: Hirasawa
authors: M
authors: M
authors: Sakai
authors: H
authors: H
authors: Saegusa
authors: K
authors: K
authors: Hayashi
authors: N
authors: N
authors: Horita
authors: H
authors: H
authors: Ohsawa
mesh_terms: D001778:Blood Coagulation Disorders / Q000503:physiopathology; D001786:Blood Glucose / Q000378:metabolism; D005342:Fibrinolysis; D005951:Glucose Tolerance Test; D006728:Hormones / Q000097:blood; D006801:Humans; D009102:Multiple Organ Failure / Q000097:blood / Q000503:physiopathology*; D019397:Pancreas, Artificial; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood / Q000502:physiology*; D018805:Sepsis / Q000097:blood / Q000628:therapy; D010959:Tissue Plasminogen Activator / Q000097:blood / Q000502:physiology*
chemical_list: D001786:Blood Glucose; D006728:Hormones; D017395:Plasminogen Activator Inhibitor 1; D010959:Tissue Plasminogen Activator